Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP)

CUSIP: 890260839

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class
Equity / Common Stock
Shares outstanding
13,418,426
Total 13F shares
284
Share change
+284
Total reported value
$3,905
Price per share
$13.75
Number of holders
1
Value change
+$3,905
Number of buys
1

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 890260839?
CUSIP 890260839 identifies TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) as of Q1 2026

As of 31 Mar 2026, Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 284 shares. The largest 1 holders included GAMMA Investing LLC. This page lists 1 institutional shareholders reporting positions in this security for the Q1 2026 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
70
Q1 2026 holders
1
Holder diff
-69
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2026 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.